Valuation: CONMED Corporation

Market Cap 1.36B 1.23B 1.14B 1.04B 1.95B 130B 1.96B 13.74B 5.36B 67.38B 5.12B 5.01B 217B P/E 2026 *
11.7x
P/E 2027 * 10.1x
Enterprise Value 2.11B 1.89B 1.77B 1.6B 3.01B 200B 3.03B 21.2B 8.28B 104B 7.91B 7.73B 335B EV / Sales 2026 *
1.54x
EV / Sales 2027 * 1.4x
Free-Float
95.39%
Yield 2026 *
-
Yield 2027 * -
1 day-0.98%
1 week+1.99%
Current month-2.42%
1 month-2.74%
3 months+8.05%
6 months+13.54%
Current year+11.11%
1 week 44.05
Extreme 44.05
46.59
1 month 43.97
Extreme 43.97
48.25
Current year 31.44
Extreme 31.44
53.66
1 year 31.44
Extreme 31.44
53.66
3 years 31.44
Extreme 31.44
117.27
5 years 31.44
Extreme 31.44
159.11
10 years 31.44
Extreme 31.44
159.11
Manager TitleAgeSince
Chief Executive Officer 60 31/12/2024
Director of Finance/CFO 53 14/07/2026
Chief Tech/Sci/R&D Officer 50 31/12/2024
Director TitleAgeSince
Director/Board Member 74 22/07/2014
Director/Board Member 60 31/12/2024
Director/Board Member 72 30/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Exercice

Director

1,000 0.0033%
15/07/26 Other

Chief Financial Officer

0 0%
15/07/26 Free

Chief Financial Officer

92,465 0.3071%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%+1.99%+1.30%-52.60% 1.36B
-0.08%+3.91%-23.02%+11.29% 178B
+0.02%+8.60%-3.81%+29.42% 119B
-1.33%+1.36%-24.55%+5.70% 108B
+1.23%+0.99%-45.59%-10.58% 75.27B
+1.02%+5.16%+4.93%+78.54% 62.99B
+0.34%+0.40%+16.65%+62.51% 53.46B
+0.03%+3.94%-0.58%-27.91% 51.04B
+0.97%+3.50%-17.66%+22.08% 40.99B
-1.50%-0.44%+26.76%+6.31% 32.1B
Average -0.02%+2.52%-6.56%+12.48% 72.21B
Weighted average by Cap. +0.02%+3.15%-12.91%+18.32%

Financials

2026 *2027 *
Net sales 1.37B 1.23B 1.15B 1.04B 1.95B 130B 1.96B 13.76B 5.37B 67.49B 5.13B 5.02B 217B 1.43B 1.29B 1.2B 1.09B 2.05B 136B 2.06B 14.44B 5.64B 70.81B 5.38B 5.27B 228B
Net income 117M 105M 97.92M 88.74M 167M 11.11B 168M 1.18B 459M 5.76B 438M 429M 18.54B 135M 121M 113M 103M 193M 12.85B 194M 1.36B 531M 6.67B 507M 496M 21.44B
Net Debt 741M 667M 622M 564M 1.06B 70.56B 1.07B 7.47B 2.92B 36.62B 2.78B 2.72B 118B 638M 574M 535M 485M 911M 60.71B 916M 6.42B 2.51B 31.51B 2.4B 2.34B 101B
Projected Income Statement - Annual - CONMED Corporation
Logo CONMED Corporation
CONMED Corporation is a medical technology company which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product line consists of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Employees
3,900
Date Price Change Volume
14/10/26 US$44.79 -1.67% 179,106
13/10/26 US$45.55 +0.42% 521,743
12/10/26 US$45.36 +2.12% 515,221
09/10/26 US$44.42 -1.53% 400,451
08/10/26 US$45.11 +1.99% 473,961
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CONMED Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
45.55USD
Average target price
45.50USD
Spread / Average Target
-0.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CONMED Corporation
  1. Stock Market
  2. Stocks
  3. CNMD Stock